“Killer” Coldrif Syrup is Banned in Delhi Because of Harmful Adulteration

The Delhi Government’s Drugs Control Department issued an immediate prohibition on sales, purchases, and distributions of Coldrif Syrup following laboratory analyses that revealed dangerous adulteration. Diethylene Glycol is a harmful substance to the human body.
This ban is the result of a thorough analysis performed by government labs earlier in the month. The results showed that Coldrif Syrup contained Diethylene Glycol and was therefore “Not Standard Quality”. It could be dangerous to consumers. The toxic substance is dangerous to health and should not be consumed.
The Drugs Control Department issued an official notification dated October 10th, 2024, stressing the urgency of taking immediate steps to safeguard public health. According to the department, its analysis revealed that cough syrup had been contaminated with dangerous chemicals, which pose a significant risk for users.
The Delhi Government’s Drugs Control Department banned Coldrif Syrup because it was adulterated with Diethylene Glycol, which is harmful to health. The regulatory authority has issued a warning to stakeholders and members of the public that they should immediately stop using and selling the product.
All pharmaceutical stakeholders, such as retailers, wholesalers, and distributors, have been issued directives by the department to cease any commercial activity related to Coldrif Syrup immediately. The pharmaceutical laws could have serious consequences for any violation of the directive.
Delhi’s healthcare professionals have received an alert about this ban, and they are now advising their patients to stop using Coldrif Syrup. The medical experts advise that those who are currently using Coldrif Syrup should seek out alternative treatments that are effective and safe.
Diethylene Glycol is present in many pharmaceutical products. This industrial solvent has been linked to kidney problems, neurological disorders, and even death in some cases. This contamination is likely the result of poor manufacturing practices or intentional adulteration.
Coldrif Syrup is not to be used and should be disposed of safely. If you experience any adverse reactions after taking this cough syrup, seek medical help immediately and notify local authorities.
The Delhi Drugs Control Department monitors the market for substandard and adulterated drugs to prevent their distribution. The department continues to strive for pharmaceutical standard by conducting regular quality tests and lab testing.
The incident shows the need to only purchase medicines from pharmacies that are licensed and ensure they have proper certification before using them. To prevent similar risks, consumers are encouraged to alert authorities about any suspect pharmaceutical products.
About Delhi Drugs Control Department
The Delhi Drugs Control Department is a department of the Delhi Government that regulates pharmaceutical products and ensures drug quality standards. It also protects public health by monitoring, enforcing and enforcing activities throughout the National Capital Territory.